These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29482839)

  • 21. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID; Krishan P; Shehmar M; Ganesan R; Gupta JK
    Hum Reprod; 2013 Nov; 28(11):2966-71. PubMed ID: 23975691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review and meta-analysis on the impact of the levonorgestrel-releasing intrauterine system in reducing risk of ovarian cancer.
    D'Alessandro G; Frigerio M; Barra F; Costantini S; Gustavino C; Ferrero S
    Int J Gynaecol Obstet; 2022 Mar; 156(3):418-424. PubMed ID: 33969485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.
    Fu Y; Zhuang Z
    Int J Clin Exp Pathol; 2014; 7(10):6419-29. PubMed ID: 25400720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ultrastructure of human endometrium is altered by administration of intrauterine levonorgestrel.
    Pakarinen PI; Lähteenmäki P; Lehtonen E; Reima I
    Hum Reprod; 1998 Jul; 13(7):1846-53. PubMed ID: 9740437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.
    Buttini MJ; Jordan SJ; Webb PM
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):316-22. PubMed ID: 19566568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the quality of cervical mucus among users of the levonorgestrel-releasing intrauterine system at different times of use.
    Moraes LG; Marchi NM; Pitoli AC; Hidalgo MM; Silveira C; Modesto W; Bahamondes L
    Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):318-22. PubMed ID: 27269613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of Benign Endometrial Polyp Recurrence Using a Levonorgestrel-releasing Intrauterine System in Premenopausal Patients: A Retrospective Cohort Study.
    Wang Y; Yang M; Huang X; Li X; Lin E; Feng Y
    J Minim Invasive Gynecol; 2020; 27(6):1281-1286. PubMed ID: 32446971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
    Morelli M; Di Cello A; Venturella R; Mocciaro R; D'Alessandro P; Zullo F
    Gynecol Endocrinol; 2013 Feb; 29(2):156-9. PubMed ID: 23134558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
    Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):274-9. PubMed ID: 25601352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.
    Ewies AA; Alfhaily F
    Obstet Gynecol Surv; 2012 Nov; 67(11):726-33. PubMed ID: 23151756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cysts: presence and persistence with use of a 13.5mg levonorgestrel-releasing intrauterine system.
    Nahum GG; Kaunitz AM; Rosen K; Schmelter T; Lynen R
    Contraception; 2015 May; 91(5):412-7. PubMed ID: 25661510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases.
    Papadakis EP; El-Nashar SA; Laughlin-Tommaso SK; Shazly SA; Hopkins MR; Breitkopf DM; Famuyide AO
    J Minim Invasive Gynecol; 2015; 22(7):1203-7. PubMed ID: 26122898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levonorgestrel-releasing intrauterine system versus oral medroxyprogesterone acetate in infertile women with endometrial hyperplasia without atypia.
    Campo G; Rebecchi A; Vanni VS; Pagliardini L; Patruno C; Papaleo E; Candiani M; Giardina P
    Reprod Biomed Online; 2021 Nov; 43(5):864-870. PubMed ID: 34629315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: A retrospective cohort study of Danish women.
    Iversen L; Fielding S; Lidegaard Ø; Hannaford PC
    Contraception; 2020 Sep; 102(3):152-158. PubMed ID: 32592798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.